GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sundrug Co Ltd (TSE:9989) » Definitions » Debt-to-EBITDA

Sundrug Co (TSE:9989) Debt-to-EBITDA : 0.00 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Sundrug Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sundrug Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. Sundrug Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. Sundrug Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円50,972 Mil. Sundrug Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sundrug Co's Debt-to-EBITDA or its related term are showing as below:

TSE:9989' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.62   Med: 0.62   Max: 0.85
Current: 0.85

During the past 13 years, the highest Debt-to-EBITDA Ratio of Sundrug Co was 0.85. The lowest was 0.62. And the median was 0.62.

TSE:9989's Debt-to-EBITDA is ranked better than
72.66% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 2.555 vs TSE:9989: 0.85

Sundrug Co Debt-to-EBITDA Historical Data

The historical data trend for Sundrug Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sundrug Co Debt-to-EBITDA Chart

Sundrug Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.62

Sundrug Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1.10

Competitive Comparison of Sundrug Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Sundrug Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sundrug Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sundrug Co's Debt-to-EBITDA falls into.



Sundrug Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sundrug Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(35000 + 0) / 56420
=0.62

Sundrug Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Sundrug Co  (TSE:9989) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sundrug Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sundrug Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sundrug Co (TSE:9989) Business Description

Traded in Other Exchanges
Address
1-38-1 Wakamatsu-cho, Fuchu-shi, Tokyo, JPN, 183-0005
Sundrug Co Ltd is a Japanese based company engaged in the operations and management of drugstores. Its activities are divided into business divisions including Drugstore business, Dispensing pharmacy business, and Discount store business. The company also offers necessities such as foods, cosmetics, household appliances, clothing items, car goods, sports and leisure goods, alcoholic beverages, kerosene through its discount store Direx.

Sundrug Co (TSE:9989) Headlines

No Headlines